Arjun Goyal

Co-Founder & Managing Director
Vida Ventures

Arjun Goyal is a Co-Founder and Managing Director at Vida Ventures. From 2014-2017, Arjun was an investment professional at 5AM Ventures, a life science focused venture firm. Arjun was a Board Observer at Aprea AB, Spyryx, Pear Therapeutics, Portal Instruments, Entrada, and Homology Medicines (NASDAQ: FIXX). At 5AM Ventures, Arjun was part of the founding team of Homology Medicines, a genetic medicines company and he also served as Acting VP of Business Development at Pear Therapeutics. Prior to joining 5AM Ventures, Arjun was Co-Founder and CEO, Foresight Pharmaceuticals, a biopharmaceutical company developing hormonal treatments for infectious diseases. Arjun received his B.S. in Medical Science, Diploma in French and his M.D. degree from Universities of Melbourne and Oxford. He completed his postgraduate medical training in Internal Medicine at University of Sydney. He received his M.Phil. in Bioscience Enterprise from Cambridge on a Commonwealth Scholarship and his MBA from Harvard Business School. Arjun has received several awards for his work including the American Australian Association Education Fellowship, Robert Kaplan Life Science Fellowship, Oxford Clarendon Scholarship, Gates Cambridge Scholarship and Reg Waite Award for Young Australians. He is a co-inventor on one patent and has served on the editorial board of an international scientific journal. Arjun is a Board Observer at Pionyr Immunotherapeutics and serves on the Committee for American Australian Association Education Fellowship and LifeTech Advisory Board of Swedish American Chamber of Commerce, and was on the 2016 NCI Review Committee for SBIR grants.